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63% of the increase in case notiﬁcation by DOTS programs
between 2002 and 2003.
Conclusions: Without DOTS and Public awareness program,
it is highly unlikely that countries will be able to
develop effective and sustainable tuberculosis program.
With the introduction of DOTS, achieving the global
targets for tuberculosis control has now become a realistic
proposition.
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(MDR-TB) in extrapulmonary tuberculosis cases
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A.K. Maurya1 *, S. Kant1, V.L. Nag2, R.A.S. Kushwaha1,
M. Kumar2, S. Jain2, T.N. Dhole2. 1Department of
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Background: The importance of extrapulmonary tuberculo-
sis (EPTB) among all forms of tuberculosis has not yet been
ascertained in developing countries. Multi drug resistant
tuberculosis (MDR-TB) is an increasing worldwide problem
aswell as in India. The transmission of resistance strains
is increasing day-by-day because of the rising load of
MDR-TB patients. The aim of the study to know incidence
of MDR-TB in extra pulmonary tuberculosis cases in tertiary
care hospitals in Northern India.
Materials and Methods: A total of 789 specimens
from patients of EPTB cases with varied presentation
were studied. All the samples were processed for
ZNStaining for Acid Fast bacilli and radiometric BACTEC
culture for Mycobacteria. Identiﬁcation of M. tuberculosis
complex (MTBC) was done by BACTEC NAP (p-nitro-a-
acetylamino-b-hydroxy propiophenone) differentiation test.
All M. tuberculosis isolates were recovered for radiometric
based drug susceptibility pattern against streptomycin,
isoniazid, rifampicin and ethambutol (SHRE) using the
proportion method.
Results: 165 (20.7%) of 797 patients clinically suspected
to have extra pulmonary tuberculosis were BACTEC culture
positive for mycobacteria. Out of 165 cases, 127 (77%)
were newly diagnosed and 38 (23%) previous treated
cases. On Biochemical characterization, 123 (74.5%) of the
164 isolates were identiﬁed as Mycobacterium tuberculosis
complex by NAP Test. A total of 123 (74.5%) M. tuberculosis
isolates for ﬁrstline antitubercular drug susceptibility
pattern. We observed that MDR strains (resistance to
rifampicin and isoniazid) were found in 15 (12.1%) of 123
isolates. Overall results shown that incidence of MDRTB in
EPTB case was 12.1%.
Conclusion: M. tuberculosis was present in 20.7 percent
samples. The maximum numbers of M. tuberculosis were
isolated from lymph node aspiration. Our study originates
that multi drug resistant tuberculosis is gradually increased
in extrapulmonary tuberculosis cases.
OL-037 Analysis of microRNA expression proﬁling
identiﬁes two microRNAs as potential diagnostic
markers for active tuberculosis
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disease, Huashan Hospital, Fudan University, China
Background: The biological behaviors and disease relevance
of microRNAs in the development of active tuberculosis
(ATB) are still unknown.
Methods: The expression proﬁle of microRNA under
the challenge of mycobacterium tuberculosis PPD was
ﬁrst measured using microarray in PBMCs isolated from
ATB patients and health controls (HC). The remarkably
reactive microRNAs were further validated in other cohorts
by quantitative real-time PCR (qRT-PCR). The receiver
operating characteristic (ROC) curve was plotted to evaluate
the diagnostic value of the determined PPD-responsive
microRNAs.
Result: It turned out that 14 out of 866 human microRNAs
showed signiﬁcantly higher increased expression after PPD
stimulation in ATB than in HC groups. The qRT-PCR study
validated the ﬁndings from microarray-based screen, in
which, upon PPD stimulation, miR-155 had fold change of
1.4 in HC group and 3.7 in ATB group (p < 0.0001); miR-155*
had 1.9 in HC and 4.6 in ATB group (p < 0.005). In ROC plots,
area under the curve (AUC) was 0.8972 for miR-155 and
0.7945 for miR-155*.
Conclusion: MiR-155 and miR-155* exhibited characteristic
expression by TB-speciﬁc antigen, suggesting that they can
be potential diagnostic markers under the challenge of
speciﬁc MTB antigens.
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Objective: QuantiFERON-TBGold (QFT-G) test is a recent
method in the diagnosis of latent or active tuberculosis and
shows better results. This assay based on the detection of
interferon-gamma; produced by stimulated T lymphocytes
with tuberculosis speciﬁc antigens. In this study we evaluate
the degree of usefulness of this method in detecting the
Pott’s disease.
Methods: A total of 83 cases were included in this study.
Among them few were conﬁrmed tuberculosis patients
as evidenced by the traditional clinical techniques like
Ziehl Nelsen smear, BACTEC culture, PCR IS6110 gene
and histopathology as well as they undergone surgery
for treatment. In this study nonsurgical cases were also
included, their conﬁrmation was done with the TB ELISA.
The above all cases were compared with the recent QFT-G
assay for its efﬁcacy, sensitivity and speciﬁcity in conﬁrming
the cases of both suspected and conﬁrmed tuberculosis.
Results: The study comprised of 83 cases, however 5cases
were excluded in this as they were found to be malignant.
Among the 52 surgical cases, it was found that 39 were
tested to be tuberculosis and 13 were found to be negative
by the traditional clinical techniques. However, the QFT-G
assay gives the result that among the 39 active tuberculosis
samples only 24 found to be positive. Interestingly, 1 has
given tuberculosis positive from the samples observed to
be negative by the traditional tests. Then, the sensitivity
and speciﬁcity was 62% and 92%, (p value = 0.001), 56%
and 100%, (p value = 0.009) surgical and nonsurgical
patient correspondingly. The overall 60% sensitivity and 95%
speciﬁcity (p value 0.001).
Conclusion: By analyzing the obtained results we can say
that the speciﬁcity of QFT-G was high but its sensitivity
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was low. Further, the result needs to be veriﬁed by other
laboratory diagnosis methods in case of Pott’s disease.
OL-039 Can Mycobacterium tuberculosis DNA be
detected in plasma/serum samples from
tuberculosis patients?
D. Chen1 *, B. Gu1, S.Y. Pan1, H. Wang1, Z.H. Yan1,
C. Zhao1, G.Y. Liu1. 1Department of Laboratory Medicine,
the First Afﬁliated Hospital of Nanjing Medical University,
China
Background: Tests based on PCR have shown promise for the
detection of M. tuberculosis in different clinical samples
except plasma/serum. The purpose of this study was to
know that whether M. tuberculosis DNA can be detected in
plasma/serum samples.
Methods: 43 serums and 94 plasma were collected
from 124 clinical diagnosed TB patients. Four different
M. tuberculosis DNA extraction methods, including phenol-
chloroform method, Qiagen kit, Omega kit and magnetic
bead method were compared to get higher sensitivity. One
quantitative ﬂuorescent PCR designed by this study was
used for the detection of M. tuberculosis DNA.
Results: The highest DNA extraction efﬁciency (52.8%)
and the best reproducibility (CV = 26.7%) were seen in
the magnetic bead method. And M. tuberculosis DNA can
really be detected in some samples, and 39 of the 124
(31.5%) TB patients showed M. tuberculosis DNA positive in
plasma/serum samples. Interestingly, 35.3% (12/34) smear
negative cases demonstrate M. tuberculosis DNA positive.
Conclusion: In conclusion, this is the ﬁrst study to
report the existence of circulating M. tuberculosis DNA in
plasma/serum from tuberculosis patients and showed that
the detection of M. tuberculosis DNA may provide valuable
information for the diagnosis of AFB negative TB patients.
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Objective: The emergence of multidrug-resistant (MDR)-TB
and more recently, of extensively drug-resistant (XDR)-TB is
a real threat to achieve TB control and elimination. Quick
detection of drug resistance is an urgent clinical need for
personalized treatment to control MDR-TB or XDR-TB.
Methods: We used multilocus PCR and electrospray
ionization mass spectrometry (PCR/ESI-MS) to determine the
genotype and drug resistance proﬁles for 96 Mycobacterium
tuberculosis isolates circulating in low and high endemic
regions (Shanghai, n = 49; Chongqing, n = 47) in China.
Results: The mutation proﬁles obtained by the PCR/ESI-MS
assay indicated that Principal Genetic Group 1 (PGG1) proﬁle
(87.5%) was dominant across the isolates tested in China.
The results revealed that a cluster of 11 isolates with katG
S315T & inhA promoter C-15T, rpoB S531L, and embB M306I
in Chongqing, the high TB endemic region, which was not
observed in Shanghai, the low endemic region. In addition,
another resistance mutation proﬁle with katG S315T & inhA
promoter T-8C, rpoB D516G & P564R/A, was detected in
10 isolates in high endemic region in comparison to one
in low endemic region. Drug-resistant gene mutations were
more diversiﬁed in the low endemic region than in the high
endemic region.
Conclusion: PCR/ESI-MS can provide another rapid and
accurate laboratory diagnostic tool for antituberculosis drug
resistance determination. This new technique has potential
to facilitate rapid determination of MDR-TB in China,
allowing timely guidance for individualized treatment.
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PL-006 HBV infection modeling and numerical
simulation for anti-HBV infection personalized
combination therapy
X. Chen1, L.Q. Min1 *, Y.A. Ye2, Q. Zhang1. 1University
of Science and Technology Beijing, 2Traditional Chinese
Internal Medicine Key Laboratory of China Education
Ministry, Dongzhimen Hospital, Beijing University of
Chinese Medicine, China
Background: Some chronic HBV (CHB) patients have normal
ALTs and hepatic injuries. Chinese herbal medicine and
nucleosides combination treatments may be effective for
some of such kind patients. It needs to develop an anti-HBV
infection treatment model to interpret the mechanism for
curable CHB patients with near normal liver functions.
Methods: A 57 years old male chronic HBeAg positive patient
(nucleosides-native) received Chinese Herbal Medicine (CHM
15 23 ingredients, 450 600 g) treatment two times daily
for 24 weeks, switched to CHM + Adefovir Dipivoxil for
53 weeks, then switched to CHM + Entecavir for 21 weeks.
A new differential equation model is introduced to describe
the dynamics of anti-HBV infection treatment, in which
a term is in charge of killing virus rather than infected
hepatocytes.
Results: His HBeAg got seroconversion at week 98. The
numerical simulation of the model and his HBV DNA, ALT
are shown in following ﬁgure.
Conclusions: Analysis shows that a treated CHB patient
with infective number R0 < 1 will eventually be cured. Large
value of that term makes patient’s virus be eventually
cleared without damaging hepatocytes.
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OL-041 Evaluation of serum level changes of
sCD26 & sCD30 before and after treatment
with interferon among naive chronic hepatitis B
patients
M. Alavi-Moghaddam1 *. 1Shahid Beheshti University Of
Medical Sciences, Iran
Propose: To evaluate the role of serum levels of sCD26
and sCD30 in predicting the outcome of therapy with IFNa
among naïve chronic hepatitis B patients.
